In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to compare the metabolic and electrolyte effects of a single oral dose of 320 mg
ritobegron administered alone or with a pre- and comedication with bisoprolol, propranolol
and acipimox. In addition, to compare the metabolic and electrolyte effects of a single dose
of 320 mg ritobegron with those of a single inhalatory dose of 100 μg salmeterol